Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with cancer (tumor subjects):
- A person or their legal representative is able to read, sign, and date a consent form
- The person agrees to follow the study procedures for the entire duration of the trial
- Adults aged 18 or older, of any gender
- People who have a suspected or confirmed diagnosis of kidney cancer (renal cell carcinoma), based on blood tests, ultrasound, CT, MRI, or tissue samples, and who are in generally good health
- People whose laboratory test results meet specific requirements set by the trial (confirm with trial site)
- Women who could become pregnant must have been using contraception for at least one month before the screening visit, and must agree to continue using contraception throughout the study and for a set period after it ends
- People who meet any additional selection criteria set by the trial (confirm with trial site)
For healthy volunteers:
- People who fully understand and voluntarily sign the consent form
- Adults aged 18 to 70, of any gender
- Men who weigh at least 50 kg and women who weigh at least 45 kg, with a body mass index (BMI) between 19.0 and 26.0
- People who have had no serious or ongoing conditions affecting the heart, liver, kidneys, lungs, blood, immune system, mental health, nervous system, or digestive system in the past three years, and who are in generally good health
- People whose vital signs and physical examination results show no abnormalities
- People who do not plan to have children during the trial or within 6 months after it ends, and who agree to use effective contraception and not donate eggs or sperm during that time
- People who can communicate clearly with the research team and are willing and able to follow study requirements
Who may not be able to join:
For people with cancer (tumor subjects):
- People who are unable to complete a PET/MR or PET/CT scan — for example, due to being unable to lie flat, having claustrophobia, or having a fear of radiation
- People with a known allergy or sensitivity to certain imaging agents used in the scans (targeting PSMA, CAIX, or CD70), or to their ingredients; also, people whose fasting blood sugar level is above 11.0 mmol/L before receiving the imaging agent [18F]FDG
- People who are pregnant or breastfeeding
- People who have other circumstances that make participation unsuitable (confirm with trial site)
For healthy volunteers:
- People who have any serious or unstable health condition, a recent acute illness, or a current or past cancer diagnosis
- People who are pregnant or breastfeeding
- People who have had surgery within the 6 months before the trial that the research team considers may affect how the body processes substances
- People who have taken any medications — including prescription medicines, over-the-counter medicines, or herbal medicines — within the 2 weeks before the trial
- People who have taken part in another research study involving radioactive materials within the past 12 months
- People who have any other circumstances that could affect the study results (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0086-027-83692633
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Visual and standardized uptake values assessment of lesions and biodistribution
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.